Muir-Torre Syndrome
- PMID: 30020643
- Bookshelf ID: NBK513271
Muir-Torre Syndrome
Excerpt
Muir-Torre syndrome (MTS) was first described by Muir et al. in 1967 and, independently, by Torre et al. one year later in 1968. Muir-Torre Syndrome is an autosomal dominant disorder that is a phenotypic variant of hereditary non-polyposis colorectal cancer (HNPCC) which is also known as Lynch syndrome. It is caused by mutations in DNA mismatch repair genes which results in microsatellite instability. The hallmark features of Muir-Torre syndrome are sebaceous neoplasms of the skin and visceral malignancies with colonic carcinoma being the most common. The association of mismatch repair gene mutations and visceral malignancies warrants an earlier and more frequent evaluation for malignancy.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Task Force/Committee Members. Vidal CI, Sutton A, Armbrect EA, Lee JB, Litzner BR, Hurley MY, Rating Panel. Alam M, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Robinson JK, Schaffer A. Muir-Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores. J Cutan Pathol. 2019 Jul;46(7):484-489. - PubMed
-
- McCarthy RL, Thomas CL, Isaacs F. Multiple benign adnexal tumours: Anything but benign. Australas J Dermatol. 2019 Aug;60(3):234-236. - PubMed
-
- Schierbeck J, Vestergaard T, Bygum A. Skin Cancer Associated Genodermatoses: A Literature Review. Acta Derm Venereol. 2019 Apr 01;99(4):360-369. - PubMed
Publication types
LinkOut - more resources
Full Text Sources